Back
Milestone Pharmaceuticals, Inc. 10K Form
Sell
17
MIST
Milestone Pharmaceuticals, Inc.
Last Price:
$1.39
Seasonality Move:
29.21%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-12 | 10Q | MIST/Milestone Pharmaceuticals, Inc. Quarterly |
| 2020-05-14 | 10Q | MIST/Milestone Pharmaceuticals, Inc. Quarterly |
| 2020-03-06 | 10K | MIST/Milestone Pharmaceuticals, Inc. Annual |
| 2019-11-13 | 10Q | MIST/Milestone Pharmaceuticals, Inc. Quarterly |
| 2019-08-13 | 10Q | MIST/Milestone Pharmaceuticals, Inc. Quarterly |
| 2019-06-19 | 10Q | MIST/Milestone Pharmaceuticals, Inc. Quarterly |
Receive MIST News And Ratings
See the #1 stock for the next 7 days that we like better than MIST
MIST Financial Statistics
Sales & Book Value
| Annual Sales: | $1.5M |
|---|---|
| Cash Flow: | $-12.6M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.39 |
| Price / Book: | 3.89 |
Profitability
| EPS (TTM): | -0.79590 |
|---|---|
| Net Income (TTM): | $-63.1M |
| Gross Margin: | $1.4M |
| Return on Equity: | -611.63% |
| Return on Assets: | -81.66% |
Milestone Pharmaceuticals, Inc. Earnings Forecast
Key Milestone Pharmaceuticals, Inc. Financial Ratios
-
The Gross Profit Margin over the past 5 years for MIST is 92.63%.
-
The Selling, General & Administrative Expenses for MIST have been equal to 1,117.34% of Gross Profit Margin.
-
The Research & Development expenses have been 1,193.60% of Revenue.
-
The Net Earning history of MIST is -4,078.78% of Total Revenues.
-
Per Share Earnings over the last 9 years have been positive in 3 years.
Milestone Pharmaceuticals, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | MIST |
| CUSIP: | 59935V |
| Website: | milestonepharma.com |
Debt
| Debt-to-Equity Ratio: | 1.4 |
|---|---|
| Current Ratio: | 8.01 |
| Quick Ratio: | 7.58 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 15.5 |
MIST Technical Analysis vs Fundamental Analysis
Sell
17
Milestone Pharmaceuticals, Inc. (MIST)
is a Sell
Is Milestone Pharmaceuticals, Inc. a Buy or a Sell?
-
Milestone Pharmaceuticals, Inc. stock is rated a SellThe current Milestone Pharmaceuticals, Inc. [MIST] share price is $1.38. The Score for MIST is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.